In other words, individuals carrying both FAS -1377(GG+GA) and FASL -844(TT+TC) genotypes could be at lower risk for developing cancer than those carrying either FAS-1377(GG+GA) alone, which was consistent with our results. This evidence concerns the gene FAS and cancer.